Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study - 12/04/19
Abstract |
Background |
Caregiver-oriented quality of life (QoL) research in alopecia areata is limited. No study has used a parent-tailored survey to examine the relationship between QoL and severity of alopecia as measured by Severity of Alopecia Tool (SALT) scores.
Objectives |
This is a prospective study that describes QoL in parents of pediatric patients with all subtypes of alopecia areata and investigates the relationship between QoL and severity of disease, duration of disease, and age of patients.
Methods |
Pediatric patients and their parents were invited to participate during clinic visits. Participating parents completed the Quality of Life in a Child's Chronic Disease Questionnaire (QLCCDQ) and the Family Dermatology Life Quality Index (FDLQI). A subset of children completed the Children's Dermatologic Life Quality Index (CDLQI). SALT scores at time of survey completion were recorded.
Results |
In total, 153 patients were included. Significant mild-to-moderate negative correlations were found between SALT scores and FDLQI scores, QLCCDQ scores, and QLCCDQ emotional domain scores. Age of child correlated negatively with QLCCDQ scores but not FDLQI scores. No significant correlation was found between duration of disease and FDLQI scores, QLCCDQ scores, or QLCCDQ emotional domain scores.
Limitations |
This study is limited by its small sample size and cross-sectional design.
Conclusions |
Impaired parent QoL might be associated with increasing severity of disease and age of affected child but not duration of disease. Providers should tailor counseling accordingly and help parents set realistic expectations for long-term experience with the disease.
Le texte complet de cet article est disponible en PDF.Key words : alopecia areata, alopecia totalis, alopecia universalis, hair loss, Severity of Alopecia Tool, quality of life
Abbreviations used : AA, AT, AU, CDLQI, FDLQI, QLCCDQ, QoL, SALT, SD
Plan
| Funding sources: Supported by a Pediatric Dermatologic Research Alliance grant awarded to the authors at the Children's Hospital of Philadelphia. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
Vol 80 - N° 5
P. 1389-1394 - mai 2019 Retour au numéro
Article précédent
- The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis
- Ofer Reiter, Ilit Mimouni, Michael Gdalevich, Ashfaq A. Marghoob, Assi Levi, Emmilia Hodak, Yael Anne Leshem
- Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
- Sonja Ständer, Paul Kwon, Joe Hirman, Andrew J. Perlman, Elke Weisshaar, Martin Metz, Thomas A. Luger, TCP-102 Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?